openPR Logo
Press release

Cryptococcosis Treatment Market – Global Industry Insights, Trends and Opportunity Analysis, 2016–2024

03-20-2017 04:35 PM CET | Health & Medicine

Press release from: Pharmaceutical Report By CMI

Cryptococcosis Treatment Market – Global Industry Insights,

Cryptococcosis or cryptococcal disease is a fungal disease, which in severe cases can be fatal. It is caused by either Cryptococcus neoformans or Cryptococcus gattii. Cryptococcosis is said to be acquired by inhaling contagious propagule from surroundings. Even though the accurate character of the contagious propagule is not known, the primary theory is the basidiospore produced in the course of sexual or asexual reproduction is the cause. Cryptococcosis disease symptoms include fatigue, fever, headache, blurred vision, dry cough, and confusion. Symptoms onset is often subacute, worsening progressively over more than a few weeks. The two key complications of the disease are meningitis (brain infection) and pulmonary infection or lung infection. The occurrence of cryptococcosis is increasing over the years for various reasons, such as increase in prevalence of AIDS as well as extended use of immunosuppressive drugs. These factors are likely to propel the growth of the overall cryptococcosis treatment market in the near future.

Request a sample copy of this report @ https://www.coherentmarketinsights.com/insight/request-sample/147

According to a report by National Centre for Biotechnology Information, illnesses due to Cryptococcus fungi occur on a global scale and in an extensive range of hosts, starting from patients who are strictly immunosuppressed to patients with normal immune systems. The Centers for Disease Control and Prevention (CDC) states that around 1 million cryptococcosis cases arise throughout the globe, and it is anticipated that annually, the number of deaths associated with cryptococcosis is around 650,000. Most of the cases are reported among amongst patients with complex HIV disease. However, incidence rate is high amongst the recipients of solid organ transplant and patients getting exogenous immunosuppression. Cryptococcus occurs in those with acquired and innate immunodeficiency as well.

As the AIDS population is rising at a startling rate, the likelihood of occurrence of the disease is rising proportionately. Since cryptococcosis disease is communicable in nature, and it gets transmitted from one affected person to the next, persons suffering from the disease are expected to rise in the near future. Therefore, the cryptococcosis treatment market will also show a considerable growth.

Get Discount for First Time Buyers @ https://www.coherentmarketinsights.com/insight/request-discount/147

Cryptococcosis Treatment Market Taxonomy

On the basis of type of treatment, global cryptococcosis treatment market is classified into:

o Amphotericin B
o Flucytosine
o Fluconazole
o Others

Rising prevalence of chronic diseases to fuel cryptococcosis treatment market growth

The major factor working for the increase of the worldwide cryptococcosis treatment market is the rising count of people being contaminated by the disease. As per UNAIDS, there is an estimated 36.7 million cases of AIDS in the world at the end of the year 2015. Rise in the prevalence of diseases such as AIDS will further amplify the demand for the cryptococcosis treatment. Cryptococcosis was classified as a rarely happening illness; however, now the disease is seen to be rising across the globe. Several governments are vastly interested in eliminating the disease altogether from their respective nations. The efforts put in by governments of various regions are encouraging the players in the global market to increase their overall spend on research and development activities, in order to get superior treatment alternatives. This will further aid the global market of cryptococcosis treatment to increase at a steady pace.

Request for Customization @ https://www.coherentmarketinsights.com/insight/request-customization/147

Increasing prevalence of cryptococcosis in Sub-Saharan Africa will drive the overall cryptococcosis treatment market growth

According to CDC, in 2009, there were an estimated 720,000 cases of HIV related cryptococcosis in the Sub-Saharan Africa, which is about three times the prevalence of the disease in all other parts of the world, combined. It is believed that the disease kills more people in this region than tuberculosis. Moreover, CDC also states that cryptococcosis is the fourth most fatal disease in the region. It is estimated to cause about 504,000 deaths per year. The occurrence of cryptococcosis in the region is growing at an alarming rate; hence, the market in this region is expected to grow at a significant rate over the forecast period.

Click here to know more about this report @ https://www.coherentmarketinsights.com/ongoing-insight/cryptococcosis-treatment-market-147

Some of the major companies operating in the global cryptococcosis treatment market are Bristol-Myers Squibb Company, Sigmapharm Laboratories LLC, Janssen Biotech, Inc. (Johnson & Johnson), Novartis AG, Abbott Laboratories, Valeant Pharmaceuticals, Inc., Pfizer, Inc., and Glenmark Pharmaceuticals.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Visit Coherent Market Insights Blog @ https://blog.coherentmarketinsights.com/
Connect with us on LinkedIn @ https://www.linkedin.com/company/coherent-market-insights

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cryptococcosis Treatment Market – Global Industry Insights, Trends and Opportunity Analysis, 2016–2024 here

News-ID: 474656 • Views:

More Releases from Pharmaceutical Report By CMI

Angina Pectoris Treatment Market - Global Industry Insights, 2025
Angina Pectoris Treatment Market - Global Industry Insights, 2025
Angina pectoris is a medical term for chest pain or discomfort, which is caused due to coronary heart disease. Angina pectoris mainly occurs when heart muscle are unable to receive adequate blood. This condition usually occurs when one or more of the heart’s arteries are narrowed or blocked, which is also known as ischemia. Angina pectoris leads to uncomfortable pressure, fullness, squeezing or pain in the center of the chest.
Angina Pectoris Treatment Market - Global Industry Insights 2025
Angina Pectoris Treatment Market - Global Industry Insights 2025
Angina pectoris is a medical term for chest pain or discomfort, which is caused due to coronary heart disease. Angina pectoris mainly occurs when heart muscle are unable to receive adequate blood. This condition usually occurs when one or more of the heart’s arteries are narrowed or blocked, which is also known as ischemia. Angina pectoris leads to uncomfortable pressure, fullness, squeezing or pain in the center of the chest.
Glucagon-Like Peptide-1 (Glp-1) Analogs Market - Global Industry Insights - 2025
Glucagon-Like Peptide-1 (Glp-1) Analogs Market - Global Industry Insights - 2025
Glucagon-like peptide-1 (GLP-1) analogs also known as incretin mimetics are class of drugs indicated for type-2 diabetes mellitus to lower the blood sugar level. GLP-1 analogs prevents the breakdown of GLP-1, thereby enhancing the glucose depended insulin release, suppresses the glucagon release (which reduces hepatic glucose output), and reduces gastric emptying rate (resulting in weight loss from reduced appetite). GLP-1 analogs do not cause hypoglycemia like other class of anti-diabetic
U.S. Opioids Market to Surpass US$ 18,985.4 Million Threshold by 2024
U.S. Opioids Market to Surpass US$ 18,985.4 Million Threshold by 2024
Opioids Crisis – Public Health Emergency Opioids are the class of drugs that include illicit drugs such as heroin, codeine, fentanyl, meperidine, methadone, morphine, hydrocodone, diphenoxylate, hydromorphone, methylphenidate, oxycodone, and oxymorphone, which are generally prescribed for pain management. Opioids are also prescribed for treatment of cough and diarrhea. According to the survey conducted by Center for Behavioral Health Statistics and Quality (CBHSQ), in 2015, out of 20.5 million about 2 million

All 5 Releases


More Releases for Cryptococcosis

Cryptococcosis Market Future Prediction Report By 2031
Cryptococcosis Market business research report assesses the current as well as upcoming performance of the market, also brand-new trends in the market. It provides product overview and highlights of product and application segments of the market including price, revenue, sales, sales growth rate, and market share by product. The market statistics within the report is displayed in a statistical format to offer a better understanding upon the market dynamics. Download
Cryptococcosis Market Opportunities, Business Forecast To 2029
According to Precision Business Insights (PBI), latest report cryptococcosis market was valued at USD 5,273.5 million in 2022, growing at an 4.5% CAGR from 2023 to 2029. The market for cryptococcosis is driven by the prevalence of low immunity among a large portion of the population brought on by smoking, alcohol use, poor nutrition, rising disease prevalence, and stress, which makes it easier to contract the disease. Furthermore, an increase
Cryptococcosis Market to Develop Rapidly by 2031, TMR Study
The global cryptococcosis market is estimated to attain a valuation of US$ 4.9 Bn by the end of 2027, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 4.3% during the forecast period, 2019 to 2027. The key objective of the TMR report is to offer a complete assessment of the global market including major leading stakeholders
Cryptococcosis Market Growth Opportunities from 2022 - 2031, TMR Study
The global cryptococcosis market is estimated to attain a valuation of US$ 4.9 Bn by the end of 2027, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 4.3% during the forecast period, 2019 to 2027. The key objective of the TMR report is to offer a complete assessment of the global market including major leading stakeholders
Lupin Limited launched Ancobon Capsules’ for cryptococcosis treatment market
The growing prevalence of cryptococcus disease is escalating the growth of the cryptococcosis treatment market. The Centers for Disease Control and Prevention (CDC) states that around 1 million cryptococcosis cases arise throughout the globe, and it is anticipated that annually, the number of deaths associated with cryptococcosis is around 650,000. Most of the cases are reported among patients with complex HIV disease. Moreover, rising count of people being contaminated by
Cryptococcosis Treatment Market Opportunity Analysis, 2018-2026
Cryptococcosis or cryptococcal disease is a fungal disease, which in severe cases can be fatal. It is caused by either Cryptococcus neoformans or Cryptococcus gattii. Cryptococcosis is said to be acquired by inhaling contagious propagule from surroundings. Even though the accurate character of the contagious propagule is not known, the primary theory is the basidiospore produced in the course of sexual or asexual reproduction is the cause. Cryptococcosis disease symptoms